Navigation Links
Human Vaccines & Immunotherapeutics Special Focus Highlights a Paradigm Shift in Cancer Vaccine Development
Date:8/27/2012

FREDERICK, Md., Aug. 27, 2012 /PRNewswire/ -- Vaccinogen, Inc. today announced Dr. Michael G. Hanna, Jr., Vaccinogen CEO and co-founder, has served as guest-editor and contributor for the Human Vaccines & Immunotherapeutics Special Focus on cancer vaccines and immunotherapeutics, one of the most comprehensive peer-reviewed discussions published on the field. The Special Focus highlights nearly two decades of research and clinical development programs and, for the first time, identifies tumor heterogeneity among the factors in the success or failure of cancer immunotherapies. The Special Focus also includes direct commentary on the technology platforms for products, clinical trial design issues, and manufacturing hurdles that factor into cancer vaccine development. Dr. Hanna contributed to an introductory overview of the cancer vaccine field, authored a paper on Vaccinogen's lead product OncoVAX®, and provided the summary titled "Cancer vaccines: Are we there yet?"

"There is a new paradigm in patient-specific immunotherapy using cancer vaccines. For decades, researchers developed cancer vaccines using off the shelf presumptive antigen(s) based on a false premise that cancer cells are alike, or homogeneous," said Dr. Hanna. "The vast amount of second generation DNA sequencing data generated over the past few years has clearly demonstrated that tumors are not homogenous. Instead there is heterogeneity in and among tumors of the same classification and pathological stage. These facts indicate that the best immunotherapeutic benefits will be achieved using patient specific therapies.  Vaccinogen's Phase III cancer vaccine for Stage II colon cancer, called OncoVAX, uses this validated approach with the patient's own live tumor cells as the source of the vaccine."

Ronald Ellis, Ph.D, Editor-in-Chief of Human Vaccines & Immunotherapeutics, said, "One of the central themes attributing to the success and failure of cancer vacci
'/>"/>

SOURCE Vaccinogen, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Selfhelp Community Services and FEGS Health & Human Services Launch New Care Management Company: SinglePoint Care Network to Coordinate Care for Seniors & Others With Chronic Medical Conditions in Managed Long Term Care Market
2. Human Circuit Recognized as an Industry Leader in Commercial Integrator Magazines Business Series as a Top 5 Healthcare Market Media Integrator for 2012
3. Fetal Surveillance Company, PeriGen, Inc., to Collaborate with National Institute of Child Health and Human Development to Research Fetal Heart Rate Patterns During Labor
4. CeeTox and Cellular Dynamics Collaborate to Offer Predictive In Vitro Test for Cardiotoxicity Using Human iPSC-derived Cells
5. NIH Director Francis S. Collins, M.D., Ph.D. Selected as 2012 Pro Bono Humanum Honoree by Prix Galien USA
6. Man Without Human Heart Hikes More Than 400 Miles
7. Robai Offers Cyton Gamma Humanoid Robot Arm
8. Hologic Human Papillomavirus (HPV) High-Risk Test Approved for Use in The Netherlands Population Cervical Screening Programme
9. Grifols Initiates Safety Study of Inhaled Alpha1-Proteinase Inhibitor (Human) Following Orphan Drug Designation for Cystic Fibrosis
10. The Healing Power of Human Milk
11. China Biologic Receives SFDA Manufacturing Approval Certificate for Human Coagulation Factor VIII
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... and MENLO PARK, Calif. , Aug. ... DMPI), developer of advanced cancer therapeutics , will ... Annual Rodman & Renshaw Global Investment Conference, sponsored by ... take place Tuesday, September 9th at 2:55 p.m. EDT ... New York Palace Hotel in New York ...
(Date:8/27/2014)... 2014  Decision Resources Group finds that physicians ... rheumatology, gastroenterology, endocrinology and nephrology) expect the robustness ... has been assessed in to be the strongest ... prescribe. Other key findings from ... Acceptance of Biosimilars Across Physician Specialties ...
(Date:8/27/2014)... TAMPA, Fla. , Aug. 27, 2014 ... announced today that it has released a preview of ... helping the pharmaceutical industry avoid drug shortages and maintain ... world-wide. The Plan, a first for ... pharmaceutical and biopharmaceutical industry members and describes how industry ...
Breaking Medicine Technology:DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 2DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 3DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 4Surveyed Physicians Expect to Choose Between Future Biosimilars Based on Robustness and Number of Clinical Trials 2ISPE Releases First Look at its Plan to Prevent Drug Shortages 2ISPE Releases First Look at its Plan to Prevent Drug Shortages 3ISPE Releases First Look at its Plan to Prevent Drug Shortages 4
(Date:8/27/2014)... August 27, 2014 Reviewing the prices ... now be easier for the public when using the ... are promoted in all 50 states in the U.S. ... The different insurers that are generating the rates information ... for adults to use the programmed system without charge. ...
(Date:8/27/2014)... 2014 The New York Mobility Club ... free events about “ Sexuality & Intimacy ” for ... straightforward and entertaining discussions are for mature audiences only. ... Concord Avenue, Mamaroneck, NY) and October 7 from 6-8 ... , The New York Mobility Club is a ...
(Date:8/27/2014)... Skirt Sports , the innovative women’s running ... runner, Kathrine Switzer, most noted for her brave running of ... line of women’s running clothes that unites the history of ... Fearless Movement. , “It is such an honor ... “Kathrine is the original Skirt – she stood strong, ...
(Date:8/27/2014)... 27, 2014 Seventy-three members of the ... celebrated the beginning of their careers as healthcare professionals ... 23. Students entering a four-year PharmD program traditionally receive ... welcome them into the profession as colleagues dedicated to ... at the Garrison Theater in Claremont, Calif., KGI President ...
(Date:8/27/2014)... topical agents and light to kill tissue) appears to ... caused by sun damage) at three months after treatment ... , Author: Gayatri Patel, M.D., M.P.H., of ... and colleagues. , Background: AKs are rough, ... with fair complexions who have had lots of sun ...
Breaking Medicine News(10 mins):Health News:Home Insurance Prices for All 50 States Now Supplied at Consumer Insurance Portal Online 2Health News:Bussani Mobility Sponsors New York Mobility Club Meetings September 9 & October 7 for People with Disabilities, Sexuality & Intimacy Discussed by Advocate Liz Treston 2Health News:Skirt Sports Launches Clothing Line with Legendary Runner Kathrine Switzer 2Health News:Founding Class of the KGI School of Pharmacy Formally Welcomed into the Profession at a Traditional White Coat Ceremony 2Health News:Photodynamic therapy vs. cryotherapy for actinic keratoses 2
... Oct. 18 Medical Decisions Network,(MDN) announces Food ... IV Insulin Dosing Software. The MDN-CGS software is ... the dosage of,intravenous insulin administered to patients with ... sugar the body converts to energy for survival. ...
... Reduce Number Denied by President, a Few in Congress, ... will join the ranks of the uninsured, adding to ... health insurance,according to new data released today by the ... analysis, American Families Face Harsh Reality: 2,000 Children,Join the ...
... 18 Yankee Candle Company,Inc., the country,s #1 ... is,taking action in the fight against breast cancer. ... http://www.newscom.com/cgi-bin/prnh/20071018/NYTH093LOGO-b ) Yankee Candle Company created ... and research. The company is donating $1.00 from ...
... returning U.S. veterans , , THURSDAY, Oct. 18 (HealthDay News) ... when deciding how best to treat post-traumatic stress disorder ... of the data concludes. , The Institute of Medicine ... Affairs, which noted that about 12.6 percent of personnel ...
... Haas (NYSE:,ROH) announced today that it has ... used as a bonding alternative for pressure,sensitive ... like,door panels, interior pillars, instrument panels and ... before seen or thought possible,in an aqueous ...
... 18 Capsugel, the,leading global provider of dosage ... and sealing machines have now been licensed by,eight ... integral part of,the Licaps(R) Drug Delivery System, these ... machines in early stage,development and manufacturing of Phase ...
Cached Medicine News:Health News:FDA Clears MDN-CGS(R) Intravenous Insulin Dosing Software 2Health News:Families Face Harsh Reality: 2,000 Children Join the Uninsured Each Day 2Health News:Yankee Candle Company Sheds Some Light In The Fight Against Breast Cancer 2Health News:Value of Most Post-Traumatic Stress Treatments 'Uncertain' 2Health News:Value of Most Post-Traumatic Stress Treatments 'Uncertain' 3Health News:Value of Most Post-Traumatic Stress Treatments 'Uncertain' 4Health News:New Water-Based Acrylic Pressure-Sensitive Adhesive Defeats Heat and Humidity Issue 2Health News:Capsugel's Liquid Dosage Form Technology Utilized by Eight of the Top 10 Pharmaceutical Companies 2
... These specialty Eraser instruments have been ... with the right tool for situations ... a series of 25 gauge intraocular, ... discrete treatment of target tissues for ...
... itself to over 2,000 medical clinics nation ... user in mind, ChartingPlus relies heavily on ... features to improve documentation quality and increase ... Our medical content is specific to your ...
Transfer your exams to AltaPoint with our EMR Exam Word Lists. Document systems as normal and annotate exceptions to the systems in the exam. AltaPoint EMR is configured to allow a specialty to cust...
... Clinic Pro Software developed a touchscreen EHR ... spring. While a user can choose to ... practitioner to maintain eye contact while recording ... Clinic Pro EHR also runs on a ...
Medicine Products: